NP

Nirmesh Patel

Investor at Amino Collective

London, England

Overview 

Nirmesh Patel is a London-based Scientist, Founder, and Investor who has been recognized as Forbes 30under30 and was part of Y Combinator S17. With a diverse educational background including a PhD and MBA, he currently serves as a Principal at The Venture Collective (TVC) and Entrepreneur In Residence at Capital Enterprise, specializing in venture capital investments in pre-seed and seed stages within the Enterprise and Consumer Internet sectors. Notable highlights of Nirmesh Patel's career include being featured in Forbes 30under30 and participating in Y Combinator S17, demonstrating his exceptional achievements and recognition within the entrepreneurial and investment communities. His current roles as Principal at The Venture Collective (TVC) and Entrepreneur In Residence at Capital Enterprise showcase his expertise in venture capital investments, particularly in the pre-seed and seed stages within specified sectors.

Work Experience 

  • Investor

    2024 - Current

  • Board Observer

    2023

Unnatural Products is a startup pairing AI with chemistry to create treatments for drug targets.

Raised $38,000,000.00 from Human Ventures, Artis Ventures (AV), Merck Global Health Innovation Fund, The Venture Collective, LongeVC, Not Boring Capital, First Spark Ventures and Modi Ventures.

  • Board Member

    2022

  • Board Advisor

    2022

Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.

Raised $14,515,000.00 from Iaso Ventures, Good AI Capital, CJ Investment, Merck Global Health Innovation Fund, Viking Global Investors and The Venture Collective.

  • Board Observer

    2023

Orbillion Bio produces meat from the highest quality, heritage animals.

Raised $5,080,000.00 from At One Ventures, Earth Venture Capital, Metaplanet, Y Combinator and The Venture Collective.

  • Board Observer

    2023

  • Investor

    2017

    Angel Investor and Advisor to multiple startups including Infinitopes, Epoch Bio, ReynKo, Techspert, One Health Company, BettaFish etc LP @ Twin Path Ventures

  • Principal

    2021 - 2024

    Backing world class founders building transformational technologies. Investments include Orbem, Concert Bio, Ruby Bio, Entheos, Pragma Bio (Board), Coding Bio (Board), Entocycle (Observer), Unnatural Products (Observer), Orbillion (Observer), Yuri, Epoch Bio, Endpoint Health, and Pangea Botanica among others.

TVC is a transformational, early-stage venture firm backed by world class entrepreneurs and business leaders.

  • Entrepreneur In Residence

    2021 - 2023

    Accelerating research out of academia and into the clinic.

Articles About Nirmesh

Relevant Websites